AstraZeneca Pharma India Approves Surrender of Factory License
AstraZeneca Pharma India Limited has confirmed that its Administrative Committee of the Board of Directors has approved the surrender of a factory license, allowing it to be cancelled by the Department of Factories, Boilers, Industrial Safety and Health. The license had been valid up until December 31, 2026.The decision relates to the cancellation process for the factory operating under the company. The Administrative Committee’s approval formalizes the surrender of this regulatory requirement to the designated governmental authority.
Key details regarding the surrendered license are summarized below:
| Particulars | Details |
|---|---|
| Licensing Authority | Department of Factories, Boilers, Industrial Safety and Health |
| License Validity Period | December 14, 2023 to December 31, 2026 |
| Surrender Status | The company has surrendered its factory license for cancellation. |
The information provided indicates that the surrender action is complete according to the stipulated process. Regarding the impact on the listed entity and corrective actions, the documentation states that neither is applicable.
ASTRAZEN Stock Price Movement
Shares of AstraZeneca Pharma India Limited slipped by 2.34% on Wednesday, shedding ₹204.00 to close at ₹8557 per share. The stock traded amidst a volume of 3,329 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.